Skip to main content
MJFF in the News

Press Releases

Browse current and past press releases from The Michael J. Fox Foundation.

From
To
  • Default content image

    Though Safe and Tolerable, Nilotinib Does Not Show Promise for Benefit in Phase II Nilotinib for Parkinson’s Disease (NILO-PD) Trial

    Nilotinib seen to be safe and tolerable, but study strictly excluded those with heart issues or other health challenges No observed clinical benefit nor biological effect seen c-Abl remains target…

  • Default content image

    Accelerating Medicines Partnership Launches Data Knowledge Portal for Parkinson’s Disease

    NEW YORK (November 22, 2019) -- The Accelerating Medicines Partnership (AMP) program for Parkinson’s disease (PD) has launched a data portal to provide de-identified information collected from 4,298…

  • Default content image

    Michael J. Fox Foundation Honors Antonio Pisani, MD, PhD, and David G. Standaert, MD, PhD, with Bachmann-Strauss Prize for Excellence in Dystonia Research

    NEW YORK (November 18, 2019) -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) has announced Antonio Pisani, MD, PhD, associate professor of neurology at the University of Rome Tor…

  • Default content image

    Michael J. Fox Foundation Honors Andrew Singleton, PhD, with Robert A. Pritzker Prize for Leadership in Parkinson's Research

    NEW YORK (November 18, 2019) -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) has awarded the 2019 Robert A. Pritzker Prize for Leadership in Parkinson's Research to Andrew Singleton,…

  • Default content image

    The Michael J. Fox Foundation’s Edmond J. Safra Fellowship in Movement Disorders Selects Class of 2022

    Five physicians chosen to receive movement disorders clinical and research training at top-tier international academic centers Fellowship is building a global network of movement disorder…

  • Default content image

    The Michael J. Fox Foundation and Massachusetts General Hospital Announce Initiative to Engage Underrepresented Populations in Parkinson’s Research

    FIRE-UP PD study supports community engagement projects led by academic centers in Boston, Chicago, Denver and Southern Florida Goal is to broaden the base of research participants, which will…

  • Default content image

    Michael J. Fox Foundation Announces $10-million “Ken Griffin Alpha-synuclein Imaging Competition” Spurring Development of Critical and Elusive Research Tool for Parkinson’s Disease

    Funded in part through a $7.5-million gift from global business leader and dedicated philanthropist Ken Griffin, competition will incentivize research teams to race to develop a game-changing…

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.